Please login to the form below

Not currently logged in
Email:
Password:

The sound of silence puts the squeeze on generics and biosimilars

Medicines for Europe

Medicines for Europe vows to get governments talking to realise potential

Hacking Innovation

Innovation HackRB’s Lions Health event saw teams compete to protect children in China from air pollution

European CTR implementation advances ethical assessment of clinical trials

Anna KubikAssessment process is being integrated into national laws

Market dynamics, marketing and analytics

figure 1Ways to ensure that we know our market better than our competitors and use that knowledge to our advantage

Truthful consumerism

positiveAmid all the change and uncertainty of this moment, a set of core truths about our shared future is as relevant as ever

The Gallery

A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.

Webinars

Regret Minimisation

When new products approach the market the level of demand for them is often exaggerated.

Assessing early market opportunity

To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

PC: Are you Patient Centric or just Politically Correct?

Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far

Communicating innovation to payers and policy makers

Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

Country reports

The death of the cancer drugs fund?

UK flagNHS England's siloed budget and its uncertain future

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Video

Webinar: Customer engagement design

Customer engagement design pharma Webinar: Customer engagement design

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

White papers

The Pharma Wars Series

The future galaxy is complex. Where markets are more competitive and customers more segmented, you’ve got to be smarter. But not only smarter, the Jedi today needs to be everywhere

What pharma marketers can learn from growth hacking?

Growth hackers instinctively blend technical skills with creative thinking

How to choose your digital channels

Like many other areas of marketing, pharma digital communication is subject to fashion. A new technology arrives, people naturally get excited. Meanwhile, established communication technologies receive less focus (even if

Internships: Growing the pool of recruitable talent, or cheap labour?

Porterhouse Medical discusses the pros and cons of running internship programmes.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Infographics